Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00657358 · ClinicalTrials.gov registry record · NA

The Effect of Intravenous Lidocaine on Normal Sensation and Pain in Healthy Volunteers

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
22
Enrollment target

NCT00657358: Completed NA study, sponsored by University of Alabama at Birmingham.

NCT00657358 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00657358, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target

Study Summary

The purpose of this study is to study if lidocaine, given intravenously, reduces pain.

Primary Outcome

The right arm was exsanguinated by elevating it above heart level for 30 seconds, after which the arm was occluded with a standard blood pressure cuff positioned proximal to the elbow inflated to twice the participant's mean arterial pressure. Participants then performed 20 handgrip exercises of 2-second duration at 4-second intervals at 50% of their maximum grip strength. Pain was rated on a scale from 0 - 10 with 0 being no pain to 10 being the worst pain imaginable.

Interventions

  • DRUG Lidocaine

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2008-04
Est. Completion 2012-01
Phase NA
University of Alabama at Birmingham

1,160 total trials

What the finished NCT00657358 record still lists

NCT00657358 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Lidocaine is the first listed.

NCT00657358 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00657358 about?

NCT00657358 is a clinical study titled "The Effect of Intravenous Lidocaine on Normal Sensation and Pain in Healthy Volunteers". The purpose of this study is to study if lidocaine, given intravenously, reduces pain.

What is the current status of trial NCT00657358?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2008-04. Estimated completion is 2012-01.

What interventions are being tested in trial NCT00657358?

The interventions under investigation include: Lidocaine (DRUG).

Who is sponsoring clinical trial NCT00657358?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00657358's enrollment target sits among peer trials

22 1756th of 2000 higher than 239 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00657358, the US trial registry maintained by the National Library of Medicine. NCT00657358 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.